top of page
Assets
NewStem
Netco Partners
Technology
Leadership
News
Investor Relations
More
Use tab to navigate through the menu items.
In The Press
Arbitration Confirms NovelStem Joint Venture’s Rights to Exploit‘Tom Clancy’s Net Force’ Franchise
Jul 13, 2023
NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports...
May 15, 2023
NovelStem’s Affiliate NewStem Announced New Collaboration to Validate its Software Diagnostic Device
Dec 14, 2022
NovelStem Reports Third Quarter Results on Form 10-Q
Nov 14, 2022
NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding...
Oct 13, 2022
NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary
Apr 11, 2022
bottom of page
